Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report

Autor Kojima, Yasuyuki, Takahi, Yuko, Ichimaru, Naotsugu, Okumi, Masayoshi, Takahara, Shiro, Nonomura, Norio
Vydáno v BMC Res Notes (2015)

Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer

Autor Okada, Yukinori, Kobayashi, Mariko, Shinozaki, Mio, Abe, Tatsuyuki, Kanemaki, Yoshihide, Nakamura, Naoki, Kojima, Yasuyuki
Vydáno v Acta Radiol Open (2020)

MED12 exon 2 mutations in phyllodes tumors of the breast

Autor Nagasawa, Satoi, Maeda, Ichiro, Fukuda, Takayo, Wu, Wenwen, Hayami, Ryosuke, Kojima, Yasuyuki, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Vydáno v Cancer Med (2015)

Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancer: A retrospective analysis

Autor Okada, Yukinori, Abe, Tatsuyuki, Shinozaki, Mio, Tanaka, Akiko, Kobayashi, Mariko, Hiromichi, Gomi, Kanemaki, Yoshihide, Nakamura, Naoki, Kojima, Yasuyuki
Vydáno v Medicine (Baltimore) (2020)

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide

Autor Suehiro, Marii, Kojima, Yasuyuki, Takahashi, Masaki, Ito, Yuka, Keira, Takayuki, Ikegawa, Kiwako, Minatogawa, Hiroko, Tsugawa, Koichiro, Tanaka, Tsuneaki
Vydáno v Cancer Manag Res (2021)

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

Autor Fukuda, Takayo, Wu, Wenwen, Okada, Maiko, Maeda, Ichiro, Kojima, Yasuyuki, Hayami, Ryosuke, Miyoshi, Yasuo, Tsugawa, Ko-ichiro, Ohta, Tomohiko
Vydáno v Cancer Sci (2015)

aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6

Autor Ishiguro, Hitoshi, Akimoto, Kazunori, Nagashima, Yoji, Kojima, Yasuyuki, Sasaki, Takeshi, Ishiguro-Imagawa, Yukari, Nakaigawa, Noboru, Ohno, Shigeo, Kubota, Yoshinobu, Uemura, Hiroji
Vydáno 2009

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Autor Iwasa, Tsutomu, Tsurutani, Junji, Watanabe, Satomi, Kato, Ryoji, Mizuno, Yutaka, Kojima, Yasuyuki, Takashima, Tsutomu, Matsunami, Nobuki, Morimoto, Takashi, Yamamura, Jun, Ohtani, Shoichiro, Tanabe, Yuko, Yoshinami, Tetsuhiro, Takano, Toshimi, Komoike, Yoshifumi, Nakagawa, Kazuhiko
Vydáno v BMC Cancer (2019)

A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study

Autor Kubo, Makoto, Kawai, Masaaki, Kumamaru, Hiraku, Miyata, Hiroaki, Tamura, Kenji, Yoshida, Masayuki, Ogo, Etsuyo, Nagahashi, Masayuki, Asaga, Sota, Kojima, Yasuyuki, Kadoya, Takayuki, Aogi, Kenjiro, Niikura, Naoki, Miyashita, Minoru, Iijima, Kotaro, Hayashi, Naoki, Yamamoto, Yutaka, Imoto, Shigeru, Jinno, Hiromitsu
Vydáno v Breast Cancer Res Treat (2019)

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastat...

Autor Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Vydáno v Trials (2020)

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advan...

Autor Yamashita, Toshinari, Masuda, Norikazu, Saji, Shigehira, Araki, Kazuhiro, Ito, Yoshinori, Takano, Toshimi, Takahashi, Masato, Tsurutani, Junji, Koizumi, Kei, Kitada, Masahiro, Kojima, Yasuyuki, Sagara, Yasuaki, Tada, Hiroshi, Iwasa, Tsutomu, Kadoya, Takayuki, Iwatani, Tsuguo, Hasegawa, Hiroki, Morita, Satoshi, Ohno, Shinji
Vydáno v Trials (2020)

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast

Autor Nagasawa, Satoi, Kuze, Yuta, Maeda, Ichiro, Kojima, Yasuyuki, Motoyoshi, Ai, Onishi, Tatsuya, Iwatani, Tsuguo, Yokoe, Takamichi, Koike, Junki, Chosokabe, Motohiro, Kubota, Manabu, Seino, Hibiki, Suzuki, Ayako, Seki, Masahide, Tsuchihara, Katsuya, Inoue, Eisuke, Tsugawa, Koichiro, Ohta, Tomohiko, Suzuki, Yutaka
Vydáno v Commun Biol (2021)

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer

Autor Johmura, Yoshikazu, Maeda, Ichiro, Suzuki, Narumi, Wu, Wenwen, Goda, Atsushi, Morita, Mariko, Yamaguchi, Kiyoshi, Yamamoto, Mizuki, Nagasawa, Satoi, Kojima, Yasuyuki, Tsugawa, Koichiro, Inoue, Natsuko, Miyoshi, Yasuo, Osako, Tomo, Akiyama, Futoshi, Maruyama, Reo, Inoue, Jun-ichiro, Furukawa, Yoichi, Ohta, Tomohiko, Nakanishi, Makoto
Vydáno v J Clin Invest (2018)

Annual report of the Japanese Breast Cancer Society registry for 2016

Autor Kubo, Makoto, Kumamaru, Hiraku, Isozumi, Urara, Miyashita, Minoru, Nagahashi, Masayuki, Kadoya, Takayuki, Kojima, Yasuyuki, Aogi, Kenjiro, Hayashi, Naoki, Tamura, Kenji, Asaga, Sota, Niikura, Naoki, Ogo, Etsuyo, Iijima, Kotaro, Tanakura, Kenta, Yoshida, Masayuki, Miyata, Hiroaki, Yamamoto, Yutaka, Imoto, Shigeru, Jinno, Hiromitsu
Vydáno v Breast Cancer (2020)

Colorectal laterally spreading tumors show characteristic expression of cell polarity factors, including atypical protein kinase C λ/ι, E-cadherin, β-catenin and basement membrane...

Autor ICHIKAWA, YASUSHI, NAGASHIMA, YOJI, MORIOKA, KAORI, AKIMOTO, KAZUNORI, KOJIMA, YASUYUKI, ISHIKAWA, TAKASHI, GOTO, AYUMU, KOBAYASHI, NORITOSHI, WATANABE, KAZUTERU, OTA, MITSUYOSHI, FUJII, SHOICHI, KAWAMATA, MAYUMI, TAKAGAWA, RYO, KUNIZAKI, CHIKARA, TAKAHASHI, HIROKAZU, NAKAJIMA, ATSUSHI, MAEDA, SHIN, SHIMADA, HIROSHI, INAYAMA, YOSHIAKI, OHNO, SHIGEO, ENDO, ITARU
Vydáno 2014